Exelixis
Clinical trials sponsored by Exelixis, explained in plain language.
-
Brain cancer drug trial halted early – no results yet
Disease control TerminatedThis study tested the drug XL184 in 19 people whose grade IV brain tumors (a serious type of cancer) had come back after initial treatment. The goal was to see if the drug could shrink tumors or slow their growth. However, the company stopped the study early for business reasons,…
Phase: PHASE2 • Sponsor: Exelixis • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Promising prostate cancer combo study halted before results
Disease control TerminatedThis study tested a combination of two drugs, cabozantinib and abiraterone, in men with a type of advanced prostate cancer that no longer responds to hormone therapy and has spread to the bones. The goal was to see if the combination could delay cancer growth or death. However, t…
Phase: PHASE2 • Sponsor: Exelixis • Aim: Disease control
Last updated May 04, 2026 16:24 UTC